Health-related Quality of Life Analysis from KEYNOTE-426: Pembrolizumab plus Axitinib Versus Sunitinib for Advanced Renal Cell Carcinoma
- Publication date
- 1 January 2021
- Publisher
- R. Jeffrey Karnes, USA Max Kates, USA M. Pilar Laguna, The Netherlands Alastair Lamb, UK Richard S. Lee, USA Seth Lerner, USA Evangelos Liatsikos, Greece Stacy Loeb, USA Yair Lotan, USA Stephan Madersbacher, Austria Luis Martı ́nez-Pin ̃ eiro, Spain Sure